Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection

Y Zhou, B Callendret, D Xu, KM Brasky… - Journal of Experimental …, 2012 - rupress.org
Y Zhou, B Callendret, D Xu, KM Brasky, Z Feng, LL Hensley, J Guedj, AS Perelson
Journal of Experimental Medicine, 2012rupress.org
Hepatitis A virus (HAV) infection typically resolves within 4–7 wk but symptomatic relapse
occurs in up to 20% of cases. Immune mechanisms that terminate acute HAV infection, and
prevent a relapse of virus replication and liver disease, are unknown. Here, patterns of T cell
immunity, virus replication, and hepatocellular injury were studied in two HAV-infected
chimpanzees. HAV-specific CD8+ T cells were either not detected in the blood or failed to
display effector function until after viremia and hepatitis began to subside. The function of …
Hepatitis A virus (HAV) infection typically resolves within 4–7 wk but symptomatic relapse occurs in up to 20% of cases. Immune mechanisms that terminate acute HAV infection, and prevent a relapse of virus replication and liver disease, are unknown. Here, patterns of T cell immunity, virus replication, and hepatocellular injury were studied in two HAV-infected chimpanzees. HAV-specific CD8+ T cells were either not detected in the blood or failed to display effector function until after viremia and hepatitis began to subside. The function of CD8+ T cells improved slowly as the cells acquired a memory phenotype but was largely restricted to production of IFN-γ. In contrast, CD4+ T cells produced multiple cytokines when viremia first declined. Moreover, only CD4+ T cells responded during a transient resurgence of fecal HAV shedding. This helper response then contracted slowly over several months as HAV genomes were eliminated from liver. The findings indicate a dominant role for CD4+ T cells in the termination of HAV infection and, possibly, surveillance of an intrahepatic reservoir of HAV genomes that decays slowly. Rapid contraction or failure to sustain such a CD4+ T cell response after resolution of symptoms could increase the risk of relapsing hepatitis A.
rupress.org